|
Variable
|
Placebo
|
Treatment
|
|---|
|
Participants
|
75
|
75
|
|
Sex (Female %)
|
48 (64%)
|
40 (53%)
|
|
Age (years; mean ± SD)
|
62.48 ± 13.70
|
64.55 ± 12.42
|
|
Weight (kg; mean ± SD)
|
79.23 ± 22.47
|
78.53 ± 18.94
|
|
Day frequency ≥ 10 (n,%)
|
57 (76%)
|
50 (67%)
|
|
Nocturia ≥2 (n,%)
|
60 (80%)
|
70 (93%)
|
|
Urgency ≥2 (n,%)
|
62 (83%)
|
63 (84%)
|
|
Urgency incontinence≥1 (n,%)
|
33 (44%)
|
32 (43%)
|
|
Stress incontinence ≥1 (n,%)
|
9 (12%)
|
10 (13%)
|
|
Any incontinence ≥1 (n,%)
|
42 (56%)
|
35 (47%)
|
|
Only two symptoms (n,%)
|
25 (30%)
|
26 (35%)
|
|
Only three symptoms (n,%)
|
29 (39%)
|
30 (30%)
|
|
All four symptoms (n,%)
|
21 (28%)
|
19 (25%)
|
- Symptoms include urinary day frequency (≥10/day), nocturia (≥2/night), urgency (≥2/day), and incontinence (≥1/day) for ≥6 months prior to enrolling in the study; any incontinence includes urgency, stress and other incontinence
